The title compound（C（37）H（48）BrNO5, 6） was synthesized from ursolic acid and its crystal structure was determined by single-crystal X-ray diffraction analysis. The compound is of orthorhombic system, space group...The title compound（C（37）H（48）BrNO5, 6） was synthesized from ursolic acid and its crystal structure was determined by single-crystal X-ray diffraction analysis. The compound is of orthorhombic system, space group P212121 with a = 16.846（3）, b = 18.844（4）, c = 11.262（2）A, Z =4, V = 3575.1（13） A^3, Mr = 666.67, Dc = 1.239 Mg/m^3, S = 1.002, μ = 1.190 mm^-1, F（000） = 1408,the final R = 0.0831 and wR = 0.1459 for 2286 observed reflections（I 〉 2σ（I））. The crystal structure is stabilized by two intermolecular hydrogen bonds（N–H（0A）···O（2） and O（1）–H（1A）···O（3））. In the preliminary antitumor assay, the title compound 6 exhibits potent cytotoxic activity against Hep G2 and SMMC-7721 cells with IC50 values of 1.64 ± 0.21 and 1.22 ± 0.13 μM, respectively.展开更多
基金Project supported by the Natural Science Foundation of Jiangsu Province(BK20151516)the Open Fundation from Jiangsu Key Lab of Biomass-based Green Fuels and Chemicals
文摘The title compound（C（37）H（48）BrNO5, 6） was synthesized from ursolic acid and its crystal structure was determined by single-crystal X-ray diffraction analysis. The compound is of orthorhombic system, space group P212121 with a = 16.846（3）, b = 18.844（4）, c = 11.262（2）A, Z =4, V = 3575.1（13） A^3, Mr = 666.67, Dc = 1.239 Mg/m^3, S = 1.002, μ = 1.190 mm^-1, F（000） = 1408,the final R = 0.0831 and wR = 0.1459 for 2286 observed reflections（I 〉 2σ（I））. The crystal structure is stabilized by two intermolecular hydrogen bonds（N–H（0A）···O（2） and O（1）–H（1A）···O（3））. In the preliminary antitumor assay, the title compound 6 exhibits potent cytotoxic activity against Hep G2 and SMMC-7721 cells with IC50 values of 1.64 ± 0.21 and 1.22 ± 0.13 μM, respectively.
